It is the Best of Treatments, It is the Worst of Treatments: The Continuing Love‐Hate Relationship With Glucocorticoids in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

It is the Best of Treatments, It is the Worst of Treatments: The Continuing Love‐Hate Relationship With Glucocorticoids in Rheumatoid Arthritis

Published:2017-07-27 Issue:8 Volume:69 Page:1131-1133
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Mahajan Tina¹,O'Dell James R.¹

Affiliation:

1. University of Nebraska Medical CenterOmaha

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.23184

Reference11 articles.

1. The effect of a hormone of the adrenal cortex (17‐hydroxy‐11‐dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis: a preliminary report;Hench PS;Mayo Clin Proc,1949

2. Glucocorticoids and rheumatoid arthritis: Back to the future?

3. “Official View” on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements

4. Inhibition by glucocorticoids of the formation of interleukin‐1α, interleukin‐1β, and interleukin‐6; mediation by decreased mRNA stability;Amano Y;Mol Pharmacol,1993

5. Empire Rheumatism Council. Cortisone/Aspirin Trial: Multi-Centre Controlled Trial Comparing Cortisone Acetate and Acetyl Salicylic Acid in the Long-Term Treatment of Rheumatoid Arthritis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long‐Term Use of Glucocorticoids;Arthritis Care & Research;2021-10-07

2. Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis;Journal of Clinical Medicine;2020-06-26

3. Corticoterapia sistémica;EMC - Tratado de Medicina;2020-03

4. Reply;Arthritis Care & Research;2019-03-28

5. Hypothesis: Can Neuroendocrine Immune Testing in Individual Rheumatoid Arthritis Patients Guide the Benefits‐To‐Harms Ratio in Glucocorticoid Therapy? Comment on the Article by Palmowski et al;Arthritis Care & Research;2019-03-28